Furthermore, a considerable number of natural compounds targeting NRF2, such as epigallocatechin-3-gallate (EGCG) and curcumin, have been found to inhibit the aggregation of α-syn in both in vitro and in vivo models of PD [154,155,156]. This evidence concerns the gene NFE2L2 and Parkinson disease.